Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Author:

Axfors Cathrine,Janiaud Perrine,Schmitt Andreas M.,van’t Hooft Janneke,Smith Emily R.,Haber Noah A.,Abayomi Akin,Abduljalil Manal,Abdulrahman Abdulkarim,Acosta-Ampudia Yeny,Aguilar-Guisado Manuela,Al-Beidh Farah,Alejandria Marissa M.,Alfonso Rachelle N.,Ali Mohammad,AlQahtani Manaf,AlZamrooni Alaa,Anaya Juan-Manuel,Ang Mark Angelo C.,Aomar Ismael F.,Argumanis Luis E.,Averyanov Alexander,Baklaushev Vladimir P.,Balionis Olga,Benfield Thomas,Berry Scott,Birocco Nadia,Bonifacio Lynn B.,Bowen Asha C.,Bown Abbie,Cabello-Gutierrez Carlos,Camacho Bernardo,Camacho-Ortiz Adrian,Campbell-Lee Sally,Cao Damon H.,Cardesa Ana,Carnate Jose M.,Castillo German Jr. J.,Cavallo Rossana,Chowdhury Fazle R.,Chowdhury Forhad U. H.,Ciccone Giovannino,Cingolani Antonella,Climacosa Fresthel Monica M.,Compernolle Veerle,Cortez Carlo Francisco N.,Costa Neto Abel,D’Antico Sergio,Daly James,Danielle Franca,Davis Joshua S.,De Rosa Francesco Giuseppe,Denholm Justin T.,Denkinger Claudia M.,Desmecht Daniel,Díaz-Coronado Juan C.,Díaz Ponce-Medrano Juan A.,Donneau Anne-Françoise,Dumagay Teresita E.,Dunachie Susanna,Dungog Cecile C.,Erinoso Olufemi,Escasa Ivy Mae S.,Estcourt Lise J.,Evans Amy,Evasan Agnes L. M.,Fareli Christian J.,Fernandez-Sanchez Veronica,Galassi Claudia,Gallo Juan E.,Garcia Patricia J.,Garcia Patricia L.,Garcia Jesus A.,Garigliany Mutien,Garza-Gonzalez Elvira,Gauiran Deonne Thaddeus V.,Gaviria García Paula A.,Giron-Gonzalez Jose-Antonio,Gómez-Almaguer David,Gordon Anthony C.,Gothot André,Grass Guaqueta Jeser Santiago,Green Cameron,Grimaldi David,Hammond Naomi E.,Harvala Heli,Heralde Francisco M.,Herrick Jesica,Higgins Alisa M.,Hills Thomas E.,Hines Jennifer,Holm Karin,Hoque Ashraful,Hoste Eric,Ignacio Jose M.,Ivanov Alexander V.,Janssen Maike,Jennings Jeffrey H.,Jha Vivekanand,King Ruby Anne N.,Kjeldsen-Kragh Jens,Klenerman Paul,Kotecha Aditya,Krapp Fiorella,Labanca Luciana,Laing Emma,Landin-Olsson Mona,Laterre Pierre-François,Lim Lyn-Li,Lim Jodor,Ljungquist Oskar,Llaca-Díaz Jorge M.,López-Robles Concepción,López-Cárdenas Salvador,Lopez-Plaza Ileana,Lucero Josephine Anne C.,Lundgren Maria,Macías Juan,Maganito Sandy C.,Malundo Anna Flor G.,Manrique Rubén D.,Manzini Paola M.,Marcos Miguel,Marquez Ignacio,Martínez-Marcos Francisco Javier,Mata Ana M.,McArthur Colin J.,McQuilten Zoe K.,McVerry Bryan J.,Menon David K.,Meyfroidt Geert,Mirasol Ma. Angelina L.,Misset Benoît,Molton James S.,Mondragon Alric V.,Monsalve Diana M.,Moradi Choghakabodi Parastoo,Morpeth Susan C.,Mouncey Paul R.,Moutschen Michel,Müller-Tidow Carsten,Murphy Erin,Najdovski Tome,Nichol Alistair D.,Nielsen Henrik,Novak Richard M.,O’Sullivan Matthew V. N.,Olalla Julian,Osibogun Akin,Osikomaiya Bodunrin,Oyonarte Salvador,Pardo-Oviedo Juan M.,Patel Mahesh C.,Paterson David L.,Peña-Perez Carlos A.,Perez-Calatayud Angel A.,Pérez-Alba Eduardo,Perkina Anastasia,Perry Naomi,Pouladzadeh Mandana,Poyato Inmaculada,Price David J.,Quero Anne Kristine H.,Rahman Md. M.,Rahman Md. S.,Ramesh Mayur,Ramírez-Santana Carolina,Rasmussen Magnus,Rees Megan A.,Rego Eduardo,Roberts Jason A.,Roberts David J.,Rodríguez Yhojan,Rodríguez-Baño Jesús,Rogers Benjamin A.,Rojas Manuel,Romero Alberto,Rowan Kathryn M.,Saccona Fabio,Safdarian Mehdi,Santos Maria Clariza M.,Sasadeusz Joe,Scozzari Gitana,Shankar-Hari Manu,Sharma Gorav,Snelling Thomas,Soto Alonso,Tagayuna Pedrito Y.,Tang Amy,Tatem Geneva,Teofili Luciana,Tong Steven Y. C.,Turgeon Alexis F.,Veloso Januario D.,Venkatesh Balasubramanian,Ventura-Enriquez Yanet,Webb Steve A.,Wiese Lothar,Wikén Christian,Wood Erica M.,Yusubalieva Gaukhar M.,Zacharowski Kai,Zarychanski Ryan,Khanna Nina,Moher David,Goodman Steven N.,Ioannidis John P. A.,Hemkens Lars G.

Abstract

Abstract Background Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX). Methods In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung–Knapp–Sidik–Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care.

Funder

swiss national science foundation

laura and john arnold foundation

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3